Citation: | ZHANG Huili, LI Ke, ZHAO Hui, HU Guoqiang, HUANG Wenlong. Synthesis and antitumor activity of fluoroquinolone C-3 s-triazole Schiff-base carboxylic acid derivatives from pefloxacin(X)[J]. Journal of China Pharmaceutical University, 2017, 48(2): 167-171. DOI: 10.11665/j.issn.1000-5048.20170206 |
[1] |
Aldred KJ,Schwanz HA,Li G,et al.Activity of quinolone CP-115,955 against bacterial and human type II topoisomerases is mediated by different interactions[J].Biochemistry,2015,54(5):1278-1286.
|
[2] |
Pommier Y. Drugging topoisomerases: lessons and challenges[J].ACS Chem Biol,2013,8(1):82-95.
|
[3] |
Xu QJ,Hou LL,Wu ZF,et al.Synthesis and antitumor activity of fluoroquinolone C-3 bioisosteres(III):s-triazole-oxadiazole methylsulfide derivatives from pefloxacin[J].J China Pharm Univ(中国药科大学学报),2013,44(6):511-514.
|
[4] |
Sun YS,Xu QJ,Hou LL,et al.Synthesis and antitumor activity of fluoroquinolone C-3 bioisosteres(IV):s-triazole-oxadiazole methylsulfide Mannich-base derivatives[J].J China Pharm Univ(中国药科大学学报),2014,45(1):39-42.
|
[5] |
Xie YS,Gao LZ,Yan Q,et al.Synthesis and antitumor activity of fluoroquinolone C-3 isosteres(VIII):s-triazole sulfide-one thiosemicarbazone derivatives from pefloxacin[J].J China Pharm Univ(中国药科大学学报),2015,46(4):416-420.
|
[6] |
Yan Q,Wu SM,Ni LL,et al.Synthesis and antitumor activity of fluoroquinolone C-3 thiazolo[3,2-b][1,2,4] triazole-substituted pefloxacin derivatives[J].J China Pharm Univ(中国药科大学学报),2015,46(5):548-551.
|
[7] |
Liao ZQ, Dong C, Carlson KE, et al. Triaryl-substituted Schiff bases are high-affinity subtype-selective ligands for the estrogen receptor[J].J Med Chem,2014,57(8):3532-3545.
|
[8] |
Hu GQ,Wu XK,Wang X,et al.Synthesis and antitumor activity of C3 heterocyclic-substituted fluoroquinolone derivatives(I):ciprofloxacin aminothiadiazole Schiff bases[J].Acta Pharm Sin(药学学报),2008,43(11):1112-1115.
|
[9] |
Hu GQ,Hou LL,Wang GQ,et al.Synthesis and antitumor and antibacterial activities of C-3 isosteres I.Norfloxacin C-3 carbonylhydrazone derivatives[J].J China Pharm Univ(中国药科大学学报),2012,43(4):298-301.
|
[1] | LU Zhipeng, XU Qinglong, CHEN Panpan, QIN Yajuan, TANG Lijun, LI Tingyou. Research progress of radioprobes targeting fibroblast activating protein[J]. Journal of China Pharmaceutical University, 2022, 53(6): 651-662. DOI: 10.11665/j.issn.1000-5048.20220603 |
[2] | CHEN Xin, YANG Qian, YOU Qidong, GUO Xiaoke. Advances of inhibitors targeting MLL1-WDR5 protein-protein interaction[J]. Journal of China Pharmaceutical University, 2022, 53(2): 125-136. DOI: 10.11665/j.issn.1000-5048.20220201 |
[3] | FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406 |
[4] | TANG Keqin, LIN Huaqing, LI Shuhong, DONG Lixin, LU Bohong, JIANG Hong. Advances in tumor targeted nanocrystals[J]. Journal of China Pharmaceutical University, 2020, 51(4): 418-424. DOI: 10.11665/j.issn.1000-5048.20200405 |
[5] | MEI Jiahao, HONG Ze, WANG Chen. Advances of drugs in targeting cGAS-STING signaling pathway[J]. Journal of China Pharmaceutical University, 2020, 51(3): 249-259. DOI: 10.11665/j.issn.1000-5048.20200301 |
[6] | JIANG Lu, CHEN Dandan, SUN Minjie, PING Qineng, ZHANG Can. Advances of wax matrix tablets[J]. Journal of China Pharmaceutical University, 2016, 47(4): 497-502. DOI: 10.11665/j.issn.1000-5048.20160418 |
[7] | YAO Guilin, WANG Haiyong, LU Tao. Advances of the uricosuric drugs[J]. Journal of China Pharmaceutical University, 2016, 47(4): 491-496. DOI: 10.11665/j.issn.1000-5048.20160417 |
[8] | ZHANG Fangrong, WANG Wei. Advances of synthetic lipoproteins as drug nanovectors[J]. Journal of China Pharmaceutical University, 2016, 47(2): 148-157. DOI: 10.11665/j.issn.1000-5048.20160204 |
[9] | LIU Fang, SUN Haopeng, YOU Qidong. Advances in small-molecule inhibitors targeting Hsp90-Cdc37 protein-protein interaction[J]. Journal of China Pharmaceutical University, 2015, 46(3): 272-278. DOI: 10.11665/j.issn.1000-5048.20150303 |
[10] | WANG Yazhe, ZHOU Jianping, DING Yang, WANG Wei. Advances in research of biomimetic drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(3): 267-273. DOI: 10.11665/j.issn.1000-5048.20140303 |